PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 40.07
+0.47 (1.19%)
At close: Sep 23, 2026
SHE:301230 Revenue
PharmaResources (Shanghai) had revenue of 192.12M CNY in the quarter ending June 30, 2026, with 4.81% growth. This brings the company's revenue in the last twelve months to 700.02M, up 10.86% year-over-year. In the year 2025, PharmaResources (Shanghai) had annual revenue of 688.35M with 26.43% growth.
Revenue (ttm)
700.02M
Revenue Growth
+10.86%
P/S Ratio
10.14
Revenue / Employee
539.72K
Employees
1,297
Market Cap
7.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 688.35M | 143.88M | 26.43% |
| Dec 31, 2024 | 544.47M | 54.75M | 11.18% |
| Dec 31, 2023 | 489.72M | 10.83M | 2.26% |
| Jan 1, 2023 | 478.88M | 30.67M | 6.84% |
| Jan 1, 2022 | 448.21M | 165.22M | 58.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.93B |
| Novogene | 2.28B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.69B |
| Chengdu Kanghua Biological Products | 1.22B |
| Bio-Thera Solutions | 1.01B |
| R&G PharmaStudies | 939.31M |
| Zhejiang Ausun Pharmaceutical | 778.50M |
| Daan Gene | 746.91M |